BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26945286)

  • 1. Metformin and the risk of renal cell carcinoma: a case-control analysis.
    Becker C; Jick SS; Meier CR; Bodmer M
    Eur J Cancer Prev; 2017 May; 26(3):257-262. PubMed ID: 26945286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin and the risk of head and neck cancer: a case-control analysis.
    Becker C; Jick SS; Meier CR; Bodmer M
    Diabetes Obes Metab; 2014 Nov; 16(11):1148-54. PubMed ID: 25041125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis.
    Bodmer M; Becker C; Meier C; Jick SS; Meier CR
    Am J Gastroenterol; 2012 Apr; 107(4):620-6. PubMed ID: 22290402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study.
    Becker C; Jick SS; Meier CR; Bodmer M
    BMC Cancer; 2015 Oct; 15():719. PubMed ID: 26475035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and the risk of endometrial cancer: a case-control analysis.
    Becker C; Jick SS; Meier CR; Bodmer M
    Gynecol Oncol; 2013 Jun; 129(3):565-9. PubMed ID: 23523618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control analysis on metformin and cancer of the esophagus.
    Becker C; Meier CR; Jick SS; Bodmer M
    Cancer Causes Control; 2013 Oct; 24(10):1763-70. PubMed ID: 23820930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin, other antidiabetic drugs, and endometrial cancer risk: a nested case-control study within Italian healthcare utilization databases.
    Franchi M; Asciutto R; Nicotra F; Merlino L; La Vecchia C; Corrao G; Bosetti C
    Eur J Cancer Prev; 2017 May; 26(3):225-231. PubMed ID: 27222938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin does not alter the risk of lung cancer: a case-control analysis.
    Bodmer M; Becker C; Jick SS; Meier CR
    Lung Cancer; 2012 Nov; 78(2):133-7. PubMed ID: 22959242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study.
    Imfeld P; Bodmer M; Jick SS; Meier CR
    J Am Geriatr Soc; 2012 May; 60(5):916-21. PubMed ID: 22458300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of metformin and the risk of ovarian cancer: a case-control analysis.
    Bodmer M; Becker C; Meier C; Jick SS; Meier CR
    Gynecol Oncol; 2011 Nov; 123(2):200-4. PubMed ID: 21802715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History of treated hypertension and diabetes mellitus and risk of renal cell cancer.
    Zucchetto A; Dal Maso L; Tavani A; Montella M; Ramazzotti V; Talamini R; Canzonieri V; Garbeglio A; Negri E; Franceschi S; La Vecchia C
    Ann Oncol; 2007 Mar; 18(3):596-600. PubMed ID: 17158772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis.
    Bodmer M; Becker C; Meier C; Jick SS; Meier CR
    Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):280-6. PubMed ID: 22178569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma.
    Psutka SP; Boorjian SA; Lohse CM; Stewart SB; Tollefson MK; Cheville JC; Leibovich BC; Thompson RH
    Urol Oncol; 2015 Feb; 33(2):67.e15-23. PubMed ID: 25153774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes, use of antidiabetic drugs, and the risk of glioma.
    Seliger C; Ricci C; Meier CR; Bodmer M; Jick SS; Bogdahn U; Hau P; Leitzmann MF
    Neuro Oncol; 2016 Mar; 18(3):340-9. PubMed ID: 26093337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms.
    Kristensen KL; Pottegård A; Hallas J; Rasmussen LM; Lindholt JS
    J Vasc Surg; 2017 Sep; 66(3):768-774.e2. PubMed ID: 28506478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
    Kowall B; Stang A; Rathmann W; Kostev K
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes, use of metformin, and the risk of meningioma.
    Seliger C; Meier CR; Becker C; Jick SS; Proescholdt M; Bogdahn U; Hau P; Leitzmann MF
    PLoS One; 2017; 12(7):e0181089. PubMed ID: 28708856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between coffee consumption and risk of renal cell carcinoma: a meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Thamcharoen N; Panjawatanan P; Cheungpasitporn W
    Intern Med J; 2017 Dec; 47(12):1422-1432. PubMed ID: 28892303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin use and prostate cancer risk.
    Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
    Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.
    Koro CE; Bowlin SJ; Weiss SR
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):697-703. PubMed ID: 15654719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.